Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards BioNanomatrix, Princeton $200K STTR to Develop Nanofluidic Sample-Sorting System

NEW YORK (GenomeWeb News) - BioNanomatrix and Princeton University will use a $200,000 grant from the National Cancer Institute to develop a nanofluidics technology for cell fractionation, the company said today.
Under the two-year Small Technology Transfer Research grant, BioNanomatrix and Princeton’s Institute for the Science and Technology of Materials will develop a front-end sample-sorting component for the company’s BioNanomatrix whole-genome analytic platform.  
The researchers intend to develop systems that can separate out and sort whole chromosomes from one cell or from multiple cells. The company expects the new system to enable sorting of sub-cellular components by size, which will enable a number of analytic applications, including sequencing, mapping, and epigenetics, “in a real-time, dynamic, bench-top format.”
BioNanomatrix, based in Philadelphia, is a Princeton spin-out, and has exclusively licensed its technology from the school.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.